Kexing Biopharm Co., Ltd. (688136.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.23B |
| Enterprise Value | 6.48B |
| P/E Ratio | 35.36 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 2.81 |
| Price/Book Ratio | 2.39 |
| Enterprise/Revenue | 3.36 |
| Enterprise/EBITDA | 27.93 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 1.54B |
| Revenue/Share | 7.41 |
| Gross Profit | 1.54B |
| EBITDA | 255.5M |
| Net Income | 159.44M |
| Diluted EPS | 0.81 |
Balance Sheet
| Total Cash | 628.04M |
| Total Cash/Share | 3.17 |
| Total Debt | 1.42B |
| Total Debt/Equity | 0.82 |
| Current Ratio | 1.5 |
| Book Value Per Share | 8.73 |
Price History
| 52-Week Change | -55.47 |
| 52-Week High | 58 |
| 52-Week Low | 17.18 |
| Moving Average 50 Days | 21.64 |
| Moving Average 200 Days | 30.06 |
Statistics
| Average Volume | 6.16M |
| Shares Outstanding | 197.86M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 1.2 |
| Payout Ratio | 0.41 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
